Editorial & Institutional Desk

Stereotaxis (STXS) Institutional & Peer Valuation Brief: Biotechnology & Specialty Pharma vs. PCSA, CRMD, and FBIO

By the PubCo Insight Editorial Desk, edited by Brad Listermann  ·  November 18, 2026
STXS
STXS Stereotaxis, Inc.
PubCo Insight Institutional & Sector Brief: Covering Stereotaxis, Inc. (NYSE: STXS) following its 2026-11-10 Form 8-K. Prepared for PubCo Insight’s verified vault of 22,361 Active Microcap Traders, Prop Desks & Family Offices.

1. Balance Sheet, SEC Filing & Operating Context (2026-11-10 Form 8-K)

Stereotaxis, Inc. (NYSE: $STXS, market capitalization ~$18.0M), led by David Fischel, operates across clinical-stage pipeline execution, regulatory milestones, and specialty biopharma commercialization. Primary SEC EDGAR XBRL records reflect capital-markets disclosure via its 2026-11-10 Form 8-K, anchoring investor diligence around balance-sheet runway and commercial execution.

STXS price and volume
STXS price and volume, last 90 days. Source: Yahoo Finance.

2. Institutional & Family Office Peer Comparison ($PCSA, $CRMD, and $FBIO)

Across our institutional and active small-cap allocator screens benchmarking $STXS against $PCSA, $CRMD, and $FBIO, three factors stand out:

Free Public-Company AI & Investor Search Visibility Report

Stereotaxis, Inc. ($STXS) Investor Search & Diligence Audit

38 / 100
Visibility Score

Why This Costs $STXS Buyers & Volume: Before retail traders, family offices, or microcap funds buy a single share of $STXS, over 70% run a 30-second search across ChatGPT, Perplexity Finance, and TradingView. When prospective investors cannot find clean, current SEC figures or hit stale third-party data, they skip out, do not invest, and buy a peer instead. Here is what investors currently see when they search Stereotaxis, Inc.:

Investor Search SurfaceScoreWhere Prospective Buyers Are Dropping Off
ChatGPT & OpenAI Search35/100Missing root /llms.txt manifest and structured IR schema; surfaces stale baseline summaries instead of recent $STXS SEC filings.
Perplexity Finance & Citations42/100Pulls fragmented quote-scraper snippets instead of verified SEC EDGAR operating milestones and peer valuation context for $STXS.
TradingView, FactSet & Sector Screens37/100$STXS is omitted from AI discovery screens covering clinical-stage pipeline execution, regulatory milestones, and specialty biopharma commercialization due to unindexed entity and FAQPage metadata.
Turnkey Cleanup & Investor Distribution Package for Stereotaxis, Inc.: Pulse IR fixes how ChatGPT, Perplexity, TradingView, FactSet, Wikidata, and your IR page display $STXS directly from your SEC filings (requiring zero hours from your team), and then distributes your verified story to our 22,361 active microcap traders and 165 family offices and funds tracking your sector. To claim this report and review our turnkey package with CEO Brad Listermann, visit pulseir.co or call 424-250-0042.

Primary sources (SEC EDGAR)

STXS Primary SEC EDGAR Filings: https://www.sec.gov/edgar/browse/?CIK=0001289340
Compiled by the PubCo Insight Editorial & Institutional Desk from primary SEC EDGAR disclosures and market data. Published for informational and research purposes only, not investment advice or a buy/sell recommendation.
Investor relations · STXS
Is this how AI describes Stereotaxis, Inc.?
This page is the public, source-linked snapshot that investors, brokers, and AI assistants pull for STXS: EDGAR filings and recent news, no editor, no spin. When an AI engine or a financial terminal shows stale, misclassified, or missing data for your ticker, that is the first thing investors see. Pulse IR runs a free 24-hour audit of how ChatGPT, Perplexity, Google, and the major terminals currently represent STXS, and can correct it.
Get the free AI visibility audit
For company management and investor relations. Pulse IR is the investor-relations firm behind PubCo Insight.
See all STXS filings and data  ·  Uplist Radar  ·  Catalyst Radar  ·  Pulse IR Capital & Institutional Desk